+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Epidermolysis bullosa acquisita with moderately severe Dysphagia due to esophageal strictures



Epidermolysis bullosa acquisita with moderately severe Dysphagia due to esophageal strictures



Indian Journal of Dermatology 56(2): 224-227



Epidermolysis bullosa acquisita (EBA) is a chronic, autoimmune condition involving the skin and mucous membranes. Symptomatic mucosal involvement is rare, but can impact on quality of life, due to esophageal strictures and dysphagia. We report a case involving a 60-year-old male presenting with bullous skin lesions on areas of friction on his hands, feet and mouth. Milia were visible on some healed areas. Biopsy showed a subepidermal vesicle. Direct immunofluorescence showed intense linear junctional IgG and C3 at the dermo-epidermal junction. Serological tests also supported the diagnosis of EBA. Screening tests for underlying malignancies were negative. Despite treatment with systemic steroids, the patient developed increasing dysphagia, requiring further investigation with esophagoscopy and a barium swallow. Confirmation of extensive esophageal stricturing prompted adjustment of medications including an increase in systemic steroids and addition of azathioprine. Currently, the patient's disease remains under control, with improvement in all his symptoms and return of anti-basement membrane antibody levels to normal, whilst he remains on azathioprine 150 mg daily and prednisolone 5 mg daily. This case highlights the fact that the treatment of a given patient with EBA depends on severity of disease and co-morbid symptoms. Newer immunoglobulin and biological therapies have shown promise in treatment resistant disease. Considering that long-term immunosuppressants or biologicals will be required, potential side effects of the drugs should be considered. If further deterioration occurs in this patient, cyclosporin A or intravenous immunoglobulin (IV Ig) will be considered. Vigilance for associated co-morbidities, especially malignancies, should always be maintained.

(PDF emailed within 0-6 h: $19.90)

Accession: 053012258

Download citation: RISBibTeXText

PMID: 21716557

DOI: 10.4103/0019-5154.80428



Related references

Epidermolysis bullosa acquisita associated with dysphagia and stricture of esophagus. Indian Journal of Dermatology, Venereology and Leprology 82(6): 717-719, 2016

Epidermolysis bullosa acquisita (EBA) and esophageal webs: a new association. American Journal of Gastroenterology 86(10): 1518-1522, 1991

Epidermolysis bullosa acquisita and associated symptomatic esophageal webs. Archives of Dermatology 127(3): 373-377, 1991

Absence of platelet aggregation activity in blister fluids from epidermolysis bullosa dystrophica and epidermolysis bullosa acquisita. Journal of Dermatological Science 1(6): 467-468, 1990

Epidermal aspects of type VII collagen: Implications for dystrophic epidermolysis bullosa and epidermolysis bullosa acquisita. Journal of Dermatology, 2018

Nonscarring inflammatory epidermolysis bullosa acquisita with esophageal involvement and linear IgG deposits. Journal of the American Academy of Dermatology 36(2 Pt 2): 320-322, 1997

Severe ocular involvement in a patient with epidermolysis bullosa acquisita. Journal of the American Academy of Dermatology 16(2 Pt 2): 439-443, 1987

Remission of severe epidermolysis bullosa acquisita induced by extracorporeal photochemotherapy. British Journal of Dermatology 133(3): 467-471, 1995

Esophageal strictures in children with epidermolysis bullosa. Archives de Pediatrie 19(12): 1325-1329, 2013

Pathomorphogenesis of blistering in epidermolysis bullosa acquisita and epidermolysis bullosa dystrophica. Archives for Dermatological Research 254(1): 103-112, 1975

Epidermolysis bullosa acquisita in childhood. Differentiation from hereditary epidermolysis bullosa. Archives of Dermatology 125(7): 944-949, 1989

Zur pathomorphogenese der blasenbildung bei epidermolysis bullosa acquisita und epidermolysis bullosa dystrophica. Archives of Dermatological Research 254(1): 103-112, 1975

The mechanobullous diseases. Hereditary epidermolysis bullosa and epidermolysis bullosa acquisita. Journal of the American Academy of Dermatology 5(6): 745-748, 1981

Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita. Clinical Immunology 129(3): 518-519, 2008

Childhood epidermolysis bullosa acquisita associated with severe dental alterations: a case presentation. Journal of Dermatology 40(5): 410-411, 2014